Neratinib in HER2-mutant, recurrent/metastatic cervical cancer (R/M CC): Updated findings from the phase 2 SUMMIT basket trial Meeting Abstract
| Authors: | Friedman, C. F.; D'Souza, A. A.; Tinker, A. V.; Corral, E.; Gambardella, V.; Goldman, J. W.; Loi, S.; Melisko, M.; Oaknin, A.; Spanggaard, I.; VanderWalde, A. M.; Frazier, A. L.; Zhang, B.; Eli, L. D.; Solit, D. B. |
| Abstract Title: | Neratinib in HER2-mutant, recurrent/metastatic cervical cancer (R/M CC): Updated findings from the phase 2 SUMMIT basket trial |
| Meeting Title: | ESMO Congress 2022 |
| Journal Title: | Annals of Oncology |
| Volume: | 33 |
| Issue: | Suppl. 7 |
| Meeting Dates: | 2022 Sep 9-13 |
| Meeting Location: | Paris, France |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2022-09-01 |
| Start Page: | S803 |
| End Page: | S804 |
| Language: | English |
| ACCESSION: | WOS:000866211600551 |
| DOI: | 10.1016/j.annonc.2022.07.687 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 559P -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work